LCTX
Lineage Cell TherapeuticsFNYSE American / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
LCTX vs peer average
16/100
LCTX vs. peer average (F vs. C)
Grade spread
A 1 · B 3 · C 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
AMRN is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $255.3M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LCTX
Lineage Cell Therapeutics
AMRN
Amarin
Grade
F
B
Momentum
0
13
Value
41
67
Sentiment
-
58
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Constructive
Grade position vs AMRN
LCTX / AMRN
Grade Position
Below peers
LCTX vs. peer average (F vs. C)
16/100
Momentum
0
AMRNValue
41
AMRNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LCTX
AMRN is the first peer returned for this comparison set.